About the Book: Molecular Determinants of Head and Neck Cancer: 2nd Edition
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck
cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and
pharynx, and are diagnosed in over 500,000 patients worldwide each year,
accounting for 5% of all malignancies. It is estimated that approximately 50,000
patients develop head and neck cancer annually in the United States, of whom
approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is
multimodal, often combining surgery or irradiation with chemotherapy; even
successfully treated patients frequently experience durable and severe side
effects. Improving